Gene augmentation therapy for hereditary retinal degeneration caused by mutations in the PRPF31 gene

摘要

The present invention relates to methods and compositions for gene therapy of retinal pigment degeneration associated with mutations in mRNA precursor processing factor 31 (PRPF31).